Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 43598-305

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 43598-305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Cipla

Packaging label for Azacitidine Injection 100 mg/vial, a lyophilized powder for subcutaneous and intravenous use. The label indicates it is for a single-dose vial, cytotoxic agent, must be diluted, and is supplied by Dr. Reddy's Laboratories Inc. The label includes dosage and storage instructions, a barcode, and manufacturing information for Cipla Ltd and Dr. Reddy's Laboratories Limited in India.*

FDA Label Image

Carton (Carton)

Packaging label for Azacitidine For Injection 100 mg/vial, a lyophilized powder for solution by Dr. Reddy's Laboratories Inc. The label states it is for subcutaneous and intravenous use, is cytotoxic, must be diluted, and contains one single-dose vial. Storage instructions at 20-25°C and safety warnings are included.*

FDA Label Image

Vial Cipla

Label for Azacitidine For Injection 100 mg/vial by Dr. Reddy's Laboratories Inc. The lyophilized powder is for subcutaneous and intravenous use only. The label includes dosing instructions, storage conditions, and handling precautions, indicating it is a single-dose vial and a cytotoxic agent. Barcodes and expiration details are also visible.*

FDA Label Image

Vial (Vial)

Label for Azacitidine Injection 100 mg per vial, a lyophilized powder for solution indicated for subcutaneous and intravenous use. The label specifies that the product is a cytotoxic agent and must be diluted before use. It includes storage instructions, dosing notes, and manufacturer information for Dr. Reddy's Laboratories Limited, India. The label features a barcode and warning that it is for single-dose use only.*

FDA Label Image

Graph (Graph)

A Kaplan-Meier survival curve chart comparing the proportion surviving over time (months from randomization) for two groups labeled AZA and CCR. It shows survival probabilities plotted with AZA group in black having higher survival compared to CCR group in grey. The chart includes number at risk tables for both groups at various time points and states statistical results including Log-Rank p=0.0001, hazard ratio 0.58 with 95% confidence interval 0.43-0.77, and death counts for each group.*

FDA Label Image

Structure (Structure)

Chemical structure of Azacitidine depicted as a molecular diagram showing its ring structures and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.